Daniil Gataulin Analyst PerformanceSenior Research Analyst, Ophthalmology at Chardan CapitalDaniil Gataulin is a stock analyst at Chardan Capital focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Daniil Gataulin has issued 32 stock ratings, including strong buy, buy, and hold recommendations. While full access to Daniil Gataulin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniil Gataulin's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings136 Last 4 YearsBuy Recommendations87.41% 118 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution135RatingsDistribution of strong buy, buy, hold, and sell ratings by Daniil Gataulin.RatingPercentageCount Strong Buy0.7%1 ratings Buy86.7%117 ratings Hold12.6%17 ratings Sell0.0%0 ratingsOut of 135 total stock ratings issued by Daniil Gataulin at Chardan Capital, the majority (86.7%) have been Buy recommendations, followed by 12.6% Hold and 0.7% Strong Buy.Best & Worst CallsBest Call0000.0%FBRXAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CGTXJun 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.2% of companies on NASDAQ25 companiesNYSE3.8% of companies on NYSE1 companyDaniil Gataulin, an analyst at Chardan Capital, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare21 companies80.8%Technology3 companies11.5%Industrials1 company3.8%Consumer Discretionary1 company3.8%Daniil Gataulin of Chardan Capital specializes in stock coverage within the Healthcare sector, with additional focus on Technology and Industrials companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY15 companies57.7%PHARMACEUTICALS6 companies23.1%SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT2 companies7.7%MACHINERY1 company3.8%SOFTWARE1 company3.8%AUTOMOBILE COMPONENTS1 company3.8% About Daniil GataulinDr. Daniil Gataulin is a Senior Research Analyst at Chardan covering Biotech companies with a focus on ophthalmology. Dr. Daniil Gataulin joined Chardan in the summer of 2021 as a VP, Senior Research Associate covering Biotechnology. Prior to Chardan, he held a Senior Research Associate position at Raymond James, where he covered SMID biotech companies with the focus on neurology, hematology, and gene therapy. Prior to his role at Raymond James, Dr. Gataulin studied the mechanism of DNA repair and recombination in the laboratory of Dr. Doug Bishop at the University of Chicago, where he discovered a novel role for ATP hydrolysis by a DNA repair/recombination protein. Dr. Gataulin holds a BS in Cell Molecular Biology from Grand Valley State University, Master’s degree in Biotechnology from Illinois Institute of Technology, and a PhD in Molecular Genetics and Cell Biology from the University of Chicago.Follow on LinkedIn Daniil Gataulin's Ratings History at Chardan Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLASELaser Photonics11/19/2026Initiated Coverage$0.39$2.00Buy$0.0000.00% ROIVERIVeritone11/18/2026Initiated Coverage$0.36$2.00Buy$0.0000.00% ROIGCTSGCT Semiconductor11/17/2026Initiated Coverage$1.18$3.00Buy$0.0000.00% ROIWKSPWorksport11/12/2026Initiated Coverage$0.28Buy$0.0000.00% ROIWATTEnergous10/27/2026Initiated Coverage$8.44$15.00Buy$0.0000.00% ROICRVOCervoMed8/3/2026Upgrade$2.81Strong-Buy$0.0000.00% ROIKODKodiak Sciences5/11/2026Upgrade$41.01$61.00Buy$0.0000.00% ROIQUREuniQure4/30/2026Boost Price Target$19.95$37.00Buy$0.0000.00% ROICGTXCognition Therapeutics3/27/2026Reiterated Rating$1.08$4.00Buy$0.0000.00% ROIMGTXMeiraGTx3/27/2026Reiterated Rating$7.53$35.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. OCGNOcugen3/25/2026Reiterated Rating$1.96$7.00Buy$0.0000.00% ROIZURAZura Bio3/23/2026Boost Price Target$5.50$11.00Buy$0.0000.00% ROIANNXAnnexon3/20/2026Reiterated Rating$5.49$16.00Buy$0.0000.00% ROICRVOCervoMed3/18/2026Boost Price Target$4.53$21.00Buy$0.0000.00% ROIIRDOpus Genetics3/12/2026Boost Price Target$5.01$11.00Buy$0.0000.00% ROIQUREuniQure3/9/2026Boost Price Target$17.29$31.00Buy$0.0000.00% ROICRVOCervoMed3/5/2026Reiterated Rating$4.02$15.00Buy$0.0000.00% ROIOCGNOcugen3/5/2026Reiterated Rating$1.96$7.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/4/2026Boost Price Target$18.00$29.00Buy$0.0000.00% ROIQUREuniQure3/3/2026Lower Price Target$10.50$16.00Buy$0.0000.00% ROIOTLKOncobiologics2/18/2026Reiterated Rating$0.42Neutral$0.0000.00% ROIOCULOcular Therapeutix2/18/2026Reiterated Rating$6.99$21.00Buy$0.0000.00% ROIRGNXREGENXBIO2/10/2026Lower Price Target$10.31$50.00Buy$0.0000.00% ROIRGNXREGENXBIO1/29/2026Reiterated Rating$11.01$52.00Buy$0.0000.00% ROIOCGNOcugen1/20/2026Reiterated Rating$1.69$7.00Buy$0.0000.00% ROIKLRSKalaris Therapeutics12/23/2025Initiated Coverage$10.06$19.00Buy$0.0000.00% ROIANNXAnnexon12/23/2025Initiated Coverage$5.19$16.00Buy$0.0000.00% ROIANNXAnnexon12/23/2025Initiated Coverage$5.11$16.00Buy$0.0000.00% ROIKLRSKalaris Therapeutics12/23/2025Initiated Coverage$9.66$19.00Buy$0.0000.00% ROIOCULOcular Therapeutix12/9/2025Reiterated Rating$16.11$21.00Buy$0.0000.00% ROIQUREuniQure12/4/2025Reiterated Rating$22.21$53.00Buy$0.0000.00% ROIRGNXREGENXBIO11/20/2025Reiterated Rating$10.93$52.00Buy$0.0000.00% ROIFBRXForte Biosciences11/17/2025Reiterated Rating$14.08$61.00Buy$0.0000.00% ROIKODKodiak Sciences11/17/2025Reiterated Rating$19.51$14.00Neutral$000.0000.00% ROIZURAZura Bio11/14/2025Reiterated Rating$4.08$10.00Buy$0.0000.00% ROIIRDOpus Genetics11/13/2025Reiterated Rating$1.92$9.00Buy$0.0000.00% ROIOCSOculis11/11/2025Reiterated Rating$19.42$51.00Buy$0.0000.00% ROIMGTXMeiraGTx11/11/2025Reiterated Rating$8.55$35.00Buy$0.0000.00% ROIQUREuniQure11/11/2025Reiterated Rating$26.15$53.00Buy$00.0000.00% ROIIRDOpus Genetics11/7/2025Reiterated Rating$1.92$9.00Buy$0.0000.00% ROIA $247 tool for $7 (Ad)Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.See the Instant Scanner in action and claim the $7 Black Friday deal today.OCULOcular Therapeutix11/5/2025Reiterated Rating$10.90$21.00Buy$0.0000.00% ROIQUREuniQure11/3/2025Lower Price Target$34.29$53.00Buy$00.0000.00% ROIADVMAdverum Biotechnologies10/27/2025Downgrade$4.24Hold$0.0000.00% ROIIRDOpus Genetics10/16/2025Initiated Coverage$2.00$9.00Buy$0.0000.00% ROIOCSOculis10/8/2025Boost Price Target$19.06$51.00Buy$0.0000.00% ROIKODKodiak Sciences10/6/2025Reiterated Rating$15.45$14.00Neutral$00.0000.00% ROIOCULOcular Therapeutix10/2/2025Reiterated Rating$11.04$21.00Buy$0.0000.00% ROIZURAZura Bio9/30/2025Reiterated Rating$2.99$10.00Buy$0.0000.00% ROIQUREuniQure9/25/2025Boost Price Target$47.50$76.00Buy$00.0000.00% ROIOCGNOcugen9/19/2025Reiterated Rating$1.40$7.00Buy$0.0000.00% ROIOCULOcular Therapeutix9/15/2025Initiated Coverage$12.81$21.00Buy$00.0000.00% ROITRMLTourmaline Bio9/10/2025Downgrade$47.64$48.00Neutral$0.0000.00% ROIQUREuniQure9/8/2025Reiterated Rating$17.95$35.00Buy$00.0000.00% ROIRGNXREGENXBIO9/8/2025Reiterated Rating$9.71$52.00Buy$0.0000.00% ROIQUREuniQure8/29/2025Reiterated Rating$16.26$35.00Buy$00.0000.00% ROIOTLKOncobiologics8/28/2025Reiterated Rating$1.09$3.00Neutral$0.0000.00% ROIFBRXForte Biosciences8/15/2025Reiterated Rating$10.82$61.00Buy$00.0000.00% ROIZURAZura Bio8/15/2025Reiterated Rating$1.72$10.00Buy$0.0000.00% ROIOTLKOncobiologics8/15/2025Reiterated Rating$2.43$3.00Neutral$0.0000.00% ROIMGTXMeiraGTx8/15/2025Reiterated Rating$8.33$35.00Buy$00.0000.00% ROITRMLTourmaline Bio8/14/2025Reiterated Rating$21.77$70.00Buy$0.0000.00% ROIADVMAdverum Biotechnologies8/13/2025Reiterated Rating$2.58$33.00Buy$0.0000.00% ROICRVOCervoMed8/11/2025Reiterated Rating$9.85$15.00Buy$0.0000.00% ROIRGNXREGENXBIO8/8/2025Reiterated Rating$7.90$52.00Buy$00.0000.00% ROICGTXCognition Therapeutics8/8/2025Reiterated Rating$0.68$4.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/7/2025Reiterated Rating$10.58$27.00Buy$00.0000.00% ROIOCGNOcugen8/4/2025Reiterated Rating$0.99$7.00Buy$0.0000.00% ROIQUREuniQure7/29/2025Lower Price Target$13.68$35.00Buy$00.0000.00% ROICLSDClearside Biomedical7/18/2025Downgrade$0.60Neutral$0.0000.00% ROIOCGNOcugen6/24/2025Reiterated Rating$0.98$7.00Buy$0.0000.00% ROIFBRXForte Biosciences6/24/2025Reiterated Rating$12.76$61.00Buy$00.0000.00% ROIRGNXREGENXBIO6/9/2025Reiterated Rating$9.61$52.00Buy$0.0000.00% ROIQUREuniQure5/30/2025Reiterated Rating$14.67$38.00Buy$00.0000.00% ROIADVMAdverum Biotechnologies5/15/2025Reiterated Rating$1.88$33.00Buy$0.0000.00% ROIMGTXMeiraGTx5/14/2025Lower Price Target$5.15$35.00Buy$0.0000.00% ROIOCGNOcugen5/12/2025Reiterated Rating$0.67$7.00Buy$0.0000.00% ROIQUREuniQure5/12/2025Reiterated Rating$12.78$38.00Buy$00.0000.00% ROICRVOCervoMed5/12/2025Boost Price Target$9.10$15.00Buy$0.0000.00% ROIOCSOculis5/9/2025Boost Price Target$18.70$33.00Buy$00.0000.00% ROICGTXCognition Therapeutics5/8/2025Lower Price Target$0.35$4.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals5/8/2025Lower Price Target$6.09$27.00Buy$00.0000.00% ROIQUREuniQure5/6/2025Reiterated Rating$15.89$38.00Buy$00.0000.00% ROITRMLTourmaline Bio5/5/2025Reiterated Rating$16.30$70.00Buy$0.0000.00% ROITRMLTourmaline Bio4/23/2025Initiated Coverage$17.32$70.00Buy$0.0000.00% ROIUBXUNITY Biotechnology4/23/2025Reiterated Rating$0.98$4.00Buy$0.0000.00% ROIADVMAdverum Biotechnologies4/17/2025Lower Price Target$2.98$33.00Buy$0.0000.00% ROIOCSOculis4/17/2025Reiterated Rating$18.02$28.00Buy$00.0000.00% ROIQUREuniQure4/1/2025Initiated Coverage$10.60$38.00Buy$00.0000.00% ROIFBRXForte Biosciences4/1/2025Lower Price Target$7.43$61.00Buy$00.0000.00% ROICLSDClearside Biomedical3/28/2025Reiterated Rating$15.45$90.00Buy$0.0000.00% ROIA $247 tool for $7 (Ad)Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.See the Instant Scanner in action and claim the $7 Black Friday deal today.UBXUNITY Biotechnology3/25/2025Lower Price Target$1.30$4.00Buy$0.0000.00% ROICGTXCognition Therapeutics3/21/2025Lower Price Target$0.43$8.00Buy$0.0000.00% ROIRGNXREGENXBIO3/20/2025Reiterated Rating$8.50$52.00Buy$0.0000.00% ROIRGNXREGENXBIO3/14/2025Reiterated Rating$6.55$52.00Buy$0.0000.00% ROICRVOCervoMed3/13/2025Upgrade$6.17$14.00Buy$0.0000.00% ROIOCSOculis3/13/2025Reiterated Rating$18.84$28.00Buy$00.0000.00% ROIUBXUNITY Biotechnology3/10/2025Reiterated Rating$1.68$6.00Buy$0.0000.00% ROIOCGNOcugen3/6/2025Boost Price Target$0.57$7.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/6/2025Reiterated Rating$6.82$33.00Buy$00.0000.00% ROICGTXCognition Therapeutics2/26/2025Reiterated Rating$0.50$11.00Buy$0.0000.00% ROIMGTXMeiraGTx2/24/2025Reiterated Rating$7.30$36.00Buy$0.0000.00% ROIOTLKOncobiologics2/18/2025Reiterated Rating$1.87$3.00Neutral$0.0000.00% ROIOCGNOcugen2/13/2025Reiterated Rating$0.66$6.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals2/6/2025Reiterated Rating$7.80$33.00Buy$00.0000.00% ROIOCGNOcugen1/23/2025Reiterated Rating$0.75$6.00Buy$0.0000.00% ROIUBXUNITY Biotechnology1/10/2025Initiated Coverage$1.33$6.00Buy$0.0000.00% ROICRVOCervoMed12/11/2024Reiterated Rating$2.16Neutral$0.0000.00% ROIOTLKOncobiologics12/2/2024Reiterated Rating$2.05Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsRaymond James FinancialMizuhoStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.